Is antiretroviral therapy cost-effective in South Africa?
Braithwaite
R Scott
RS
Department of Medicine, Yale University School of Medicine, Connecticut Veterans Affairs Health-Care System, Connecticut, USA. ronald.braithwaite@va.gov
Tsevat
Joel
J
D044966:Anti-Retroviral Agents / Q000191:economics* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics*; D015276:Health Care Rationing; D006291:Health Policy; D006801:Humans; D011634:Public Health; D013019:South Africa
D044966:Anti-Retroviral Agents